Kansenshogaku Zasshi
Online ISSN : 1884-569X
Print ISSN : 0387-5911
ISSN-L : 0387-5911
Comparative Study of Cefuzonam (CZON) with Cefotiam in Bacterial Pneumonia and Pulmonary Suppuration
Rinzo SOEJIMAToshiharu MATSUSHIMAYoshihito NIKIHiroshi KAWANEMasayasu KAWANISHI[in Japanese]Masatoshi WATANABEJiro HINOYoshihisa NAKAGAWAShigenobu UMEKIMasaru SUMIToshio KISHIMOTOAkira SAITOIchiro NAKAYAMAMasumi TOMIZAWAShinya YASUDATetsuji KORAKUHiromichi HORIKAWAAkio HIRAYAMASoichiro UEHARAMasashi TAMURATakashi ITOFumitoshi YAMAUCHIHitoshi KOBAYASHIKazumichi MIYAYoshikatsu NEMOTOTamotsu TAKISHIMAShiro IDAMakoto TAKAHASHITadao ISEKiyoshi KONNOKotaro OIZUMIAkira WATANABEKikuo ONUMAYuji NAKAIKosaku NAGAIKenji BABAMasayuki ITOFumio ARIJITeruo HASUIKEYoichi FUKUDAIzumi HAYASHITsuguji ITOMasaaki ARAKAWAKoichi WADAMasanaga TAKATOMorito IWANAGAFusanosuke YAMASAKUYasutoshi SUZUKIOsamu SEKINENobuki AOKIMasataka KATSUShinji OKUITakashi YOKOSEYasushi UEDATadashi MIYAHARAAtsushi SAITOHideo IKEMOTOKazuyoshi WATANABEHiroyuki KOBAYASHIKota KONOHiroaki TAKEDAKeimei MASHIMOTadahiro KURASAWAHiroichi TANIMOTONaohiko CHONABAYASHIKunihiko YOSHIMURATatsuo NAKATANIKoichiro NAKATAYoshitaka NAKAMORIHiroko SUGIJunzaburo KABEYasuyuki SANOKoichiro KUDOTetsuzo WATANABEMitsuo YAMAGISHIFuyuhiko HIGASHIYuzo FUNATSUTakashi INAMATSUShinichi OKAAkio AOYAGIIppei FUJIMORIYoshio KOBAYASHIMitsuo OBANATakao OKUBOAkira ITOShigeki ODAGIRIHideo TAKAHASHITomiji MIURAKaitaro YAMABEMakio KURIHARAKenichi TAKAHASHIFumio MATSUMOTOTatsuo SATAKEKenzo TAKAGIKenichi YAMAKIRyujiro SUZUKIShigeki YOKOYAMAHitoshi IWATAMotohide SASAMOTOTomoyasu SASAKIMasatoshi IMAIMasao TANOMasahito KATOToshihiko TAKEUCHITeiichi KATOYoshimitsu HAYASHIHidekazu HANAKIYoji USAMIHideaki KUROKIFumiyuki KUZETakako MURAYAMAHideki NISHIYAMAMotokazu KATOHiroshi OKUBOYoshihiro UEDATadanao TAKEDANaotsugu KURIHARAKazuhiko TERAKAWAYuriko OKAMOTOSeibun YONEZUYube IIDAYoshihiko SAKAKIBARAKojiro YASUNAGAFumio MIKIYoshiyasu IKUNOEiji INOUEAkihito MURATAShinichi TANIZAWAKazuo SAKAMOTOHirozumi SAKAIKenzo SHIODAKeiji KOBAYASHIYoshio YAMADAKiyomichi YOSHIMARUEiro TSUBURAKoichi FUKUYAMAMasaru NAKAGAWAEiji CHIKATAYasuhiro HASEGAWAEinosuke UEDAHideki NISHIKAWAYukio NISHIMOTOMichiro YAMAKIDOAkimitsu KAMITSUNAYoshinao IHARAKazuo ITASAKAOsamu KURIMURAHirofumi FUKUHARAHideo SASAKIMasakazu TAMURAYoshiro SAWAEYukio KUMAGAIJun NAGANOHiroshi NAKANOChiharu KUBOHiroko KAWAMURAAtsushi SHINODAMasahiro TAKAMOTOTsuneo ISHIBASHIMasashi KAWAHARAYasuko HARADAKohei HARAAtsushi SAITOKeizo YAMAGUCHIYoji SUZUYAMAYoshiteru SHIGENOTakakazu KIYAKyoko YAMASHITAKazuo SASAYAMAToshiaki HAYASHIHiroshi TOMITAKinichi IZUMIKAWAKazunori SHIMOGUCHITsunetoshi KOTEDAKoichi WATANABEKazuhiro OKUNOKeizo MATSUMOTOFumishige SONODAToshiaki YOSHIDAAkira SAKAMOTOMasaru NASUYoichiro GOTOJun GOTOTakayoshi TASHIROYasuko OJIROMinoru NISHIMIYAToshinori KAWASAKISyukuro ARAKIMasayuki ANDOMoritaka SUGAToshifumi NIIBORIHidetsugu KAMIYAMAKazuko YOSHIDAFujio TANAKAKazumine KOBORIMasao NAKATOMI
Author information
JOURNAL FREE ACCESS

1986 Volume 60 Issue 8 Pages 885-910

Details
Abstract

A comparative study was conducted to objectively evaluate the efficacy and safety of Cefuzonam (CZON) with Cefotiam (CTM) used as a control drug. Subjected diseases were bacterial pneumonia and pulmonary suppuration. Each drug was administered by intravenous drip infusion 1g at a time, twice a day, for 14 days as a rule. The following are the results:
1. A total of 235 patients, 117 of CZON group and 118 of CTM group, were treated, but subjected for clinical efficacy assessment by the efficacy evaluation committee were 187 cases, 99 of CZON group and 88 of CTM group, 48 cases were excluded from the evaluation.
2. Overall clinical efficacy rates were 63.3% for CZON group and 69.0% for CTM group, with no significant difference shown between the two drug groups.
3. Clinical efficacy classified by causal bacteria showed no significant difference between the two drug groups. Bacterial eradication rates were as high as 95.2% for CZON and 80.0% for CTM, but there was no significant difference between the two.
4. Against causal bacteria, MICs of CZON were significantly superior to those of CTM.
5. As for side effects incidence and abnormality in laboratory test values, no significant difference was observed between the two groups.
6. Usefulness rate for CZON was 62.2%, whereas that for CTM was 67.8%, showing no significant difference.
From these results, CZON was proved to be a useful drug for bacterial pneumonia and pulmonary suppuration.

Content from these authors
© The Japansese Association for Infectious Diseases
Previous article Next article
feedback
Top